TARS
Tarsus Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website arsusrx.com
- Employees(FY) 87
- ISIN US87650L1035
Performance
+11.08%
1W
+48.81%
1M
+117.81%
3M
+29.95%
6M
+144.05%
YTD
+198.79%
1Y
Profile
Tarsus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
Technical Analysis of TARS 2024-11-08
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-07 10:00
- 2024-11-06 16:30
- 2024-11-06 03:30
- 2024-11-05 08:30
- 2024-11-04 19:30
- 2024-10-30 06:39
- 2024-10-18 06:41
- 2024-10-17 08:30
- 2024-10-16 20:30
- 2024-10-09 17:56
- 2024-09-25 17:00
- 2024-09-25 05:00
- 2024-08-28 17:00
- 2024-08-28 05:00
- 2024-08-11 08:20
- 2024-08-09 09:00
- 2024-08-08 18:05
- 2024-08-08 16:05
- 2024-08-08 09:56
- 2024-07-29 16:30
- 2024-07-29 04:30
- 2024-07-12 10:04
When Will Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Turn A Profit?(Simply Wall St.)
- 2024-05-29 17:00
Tarsus to Participate in Upcoming Investor Conferences(GlobeNewswire)
- 2024-05-29 05:00
Tarsus to Participate in Upcoming Investor Conferences(Globenewswire)
- 2024-05-12 08:32
- 2024-05-10 07:20
- 2024-05-09 17:00
- 2024-05-09 12:48
- 2024-05-09 11:06
- 2024-05-09 05:00
Page 1 of 7
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.